Phase III clinical trials of a vaccine developed by China's Sinovac Biotech Ltd are under way in the state of Sao Paulo, whose governor said last week it may be available to Brazilians as early as December. Japan's Nikkei .N225 firmed 0.7% after Chief Cabinet Secretary Yoshihide Suga won a landslide victory in a ruling party leadership election, paving the way for him to succeed Prime Minister Shinzo Abe.
"This is what we want to see with trials, it is a well-run trial".
In these desolate times of the Coronavirus outbreak, not only India but the world had pinned its hopes on the Oxford-AstraZeneca COVID vaccine.
The 10-year U.S. Treasury US10YT=RR note rose 0.7 basis points to 0.6739%.
Earlier in the week AstraZeneca had paused worldwide studies of its candidate vaccine after one United Kingdom participant developed symptoms consistent with the spinal cord inflammation known as transverse myelitis.
Oxford University and AstraZeneca are to resume the worldwide trial of their proposed vaccine candidate following a brief pause.
In August, South Korea said it planned to join the COVAX facility, a global novel coronavirus vaccine allocation plan co-led by the World Health Organization, which aims to help buy and fairly distribute the shots.
"The reopening of the global economy is enticing us to recommend a trade going long a basket of 14 laggard "back to work" stocks versus a basket of 14 high-flying "COVID-19 winners", BCA Research wrote in a note. About two-thirds of the needed participants have already been recruited for the studies.
Also, "the Fed is set to be less pre-emptive in tightening policy than in the past", NAB's Strickland noted. The Bank of Japan and the Bank of England announce their respective policy decisions on Thursday.
Major currencies were treading water on Monday.
Sterling GBP= was last trading at $1.2855, up 0.48% on the day, while the dollar index =USD fell 0.22%. Brent crude climbed 0.5 per cent to $40 per barrel.
In commodities, United States crude jumped 0.7 per cent to $37.58 a barrel.
USA gold futures GCv1 settled up 0.8% at $1,963.70 an ounce.